WallStreetZenWallStreetZen
Analyst Ranking
Top 13%
#523 out of 4172 analysts
Average Return
+14.29%
Win Rate
56%15 out of 27
Risk vs Reward
Poor
Good

Dan Brennan's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Avantor IncAVTR
+139.46%$13.81$33.07
2020-04-27 -
2021-04-28
Strong Buy
Charles River Laboratories International IncCRL
+99.52%$160.89$321.01
2020-05-12 -
2021-05-13
Strong Buy
Ppd IncPPD
+96.60%$23.50$46.20
2020-04-27 -
2021-04-28
Strong Buy
Exact Sciences CorpEXAS
+76.13%$77.17$135.92
2020-04-27 -
2021-04-28
Strong Buy
Maravai Lifesciences Holdings IncMRVI
+56.16%$25.73$40.18
2020-12-13 -
2021-12-13
Strong Buy

Dan Brennan Analyst Color

Get additional color on Dan Brennan's coverage of popular stocks

Dan Brennan's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Neogenomics IncNEO
3Buy$20.00+15.34%Maintains
a month ago
Exact Sciences CorpEXAS
4Buy$76.00+13.74%Maintains
a month ago
10x Genomics IncTXG
2Buy$57.00+14.55%Maintains
a month ago
Thermo Fisher Scientific IncTMO
4Buy$711.00+26.58%Maintains
2 months ago
Danaher CorpDHR
1Buy$320.00+29.05%Maintains
2 months ago
Maravai Lifesciences Holdings IncMRVI
2Hold$16.00+16.19%Downgrades
3 months ago
Nanostring Technologies IncNSTG
1Buy$24.00+166.67%Maintains
5 months ago
Avantor IncAVTR
2Hold$28.00+32.70%Downgrades
6 months ago
Illumina IncILMN
2Hold$245.00+12.48%Maintains
7 months ago
Somalogic IncSLGC
3Buy$9.00+281.36%Maintains
7 months ago
Invitae CorpNVTA
2Hold$2.50+98.41%Downgrades
8 months ago
Iqvia Holdings IncIQV
1Strong Buy$310.00N/AMaintains
a year ago
Charles River Laboratories International IncCRL
2Strong Buy$465.00N/AMaintains
2 years ago
Icon PLCICLR
1Strong Buy$232.00N/AUpgrades
2 years ago
Mettler Toledo International IncMTD
2Strong Sell$880.00N/ADowngrades
2 years ago
Ppd IncPPD
2Strong Buy$32.00N/AMaintains
3 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.